Search results
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In...
Benzinga via Yahoo Finance· 2 weeks agoRecently listed Alto Neuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase...
Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc
GuruFocus.com via Yahoo Finance· 3 months agoOn February 6, 2024, Point72 Asset Management, led by Steven Cohen (Trades, Portfolio), made a...
Alto Neuroscience (ANRO): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 1 month agoOne stock that might be an intriguing choice for investors right now is Alto Neuroscience Inc. ANRO....
A scientist quit Stanford to chase a new way to treat depression. He just shared an early sign that...
Business Insider via Yahoo News· 1 year agoDr. Amit Etkin is the founder and CEO of Alto Neuroscience.Alto Neuroscience Alto Neuroscience is...
Brain drug developer Alto Neuroscience prices $129M IPO
BioPharma Dive via Yahoo Finance· 3 months agoThe biotech was joined by Fractyl Health in pricing an IPO Thursday evening, adding to last month’s...
The stock of psychedelics giant Atai is tumbling after a treatment failed to help patients in a...
Business Insider via Yahoo News· 1 year agoA doctor prepares to give intravenous ketamine at a clinic in Palo Alto, California in 2019.Yalonda...
Analysts Bet Big on These Beaten-Down IPO Stocks
TipRanks via Yahoo Finance· 2 months agoNew public stock offerings – IPOs – are among the most exciting aspects of the stock markets. They are the face of the market’s dynamism, and rightly so....
Insiders are Piling into These 10 Healthcare Stocks in 2024
Insider Monkey via Yahoo Finance· 1 month agoIn this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks...
Researchers see promise in gene therapy for chronic drinkers
United Press International via Yahoo News· 9 months agoKathleen Grant, professor and chief of the Division of Neuroscience at the Oregon Health and Science...
Engrail’s precision psychiatry drugs get more buy in from venture investors
BioPharma Dive via Yahoo Finance· 2 months agoEngrail Therapeutics, a San Diego-based biotechnology company, has raised another $157 million to...
